OXCARBAZEPINE Side Effects

7006508-7 | Convulsion, Product Substitution Issue
on Sep 21, 2010 Female patient from UNITED STATES , 18 years of age, weighting 150.0 lb, was diagnosed with convulsion and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, product substitution issue. Oxcarbazepine dosage: 150mg Bid Po.

7005070-2 | Condition Aggravated, Convulsion
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: condition aggravated, convulsion on Sep 06, 2010 from CANADA Additional patient health information: Female patient , 48 years of age, was diagnosed with convulsion and. Oxcarbazepine dosage: 300 Mg;bid, Po. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), DIVALPROEX SODIUM (View Divalproex Sodium Review and Divalproex Sodium Label ), LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODUM) (View Levothyroxine Sodium (levothyroxine Sodum) Review and Levothyroxine Sodium (levothyroxine Sodum) Label ).

6979637-1 | Neutropenia
Adverse event was reported on Sep 10, 2010 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 300mg Bid Po) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , child 12 years of age, After Oxcarbazepine was administered, patient had the following side effects: neutropenia.

6933039-2 | Abdominal Pain Upper, Blood Sodium Decreased, Confusional State, Lethargy, Product Substitution Issue
on Aug 18, 2010 Female patient from UNITED STATES , 52 years of age, weighting 115.0 lb, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood sodium decreased, confusional state, lethargy, product substitution issue. Oxcarbazepine dosage: 1 3 X Daily Oral. During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SYTHTHROID (View Syththroid Review and Syththroid Label ), LIPITOR (View Lipitor Review and Lipitor Label ), BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized and became disabled.


6929787-0 | International Normalised Ratio Decreased
on Aug 04, 2010 Male patient from GERMANY , 16 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: international normalised ratio decreased. Oxcarbazepine dosage: Unk. During the same period patient was treated with WARFARIN (10 Mg, Unk) (View Warfarin Review and Warfarin Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6926337-X | Grand Mal Convulsion
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: grand mal convulsion on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , 18 years of age, weighting 120.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Oxcarbazepine dosage: 150mg 1 At Bedtime Po. Patient was hospitalized.

6915330-9 | Erythema, Urticaria
Adverse event was reported on Aug 06, 2010 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: 1 Tab Bid Po) was diagnosed with neuralgia and. Location: UNITED STATES , 70 years of age, weighting 220.0 lb, Patient experienced the following unwanted or unexpected effects: erythema, urticaria.

6910288-0 | Agitation, Dysarthria, Somnolence
on Jul 23, 2010 Male patient from GERMANY , 13 years of age, weighting 103.6 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: agitation, dysarthria, somnolence. Oxcarbazepine dosage: 900 Mg, Unk. During the same period patient was treated with VALPROATE SODIUM (2000 Mg, Unk) (View Valproate Sodium Review and Valproate Sodium Label ), KEPPRA (2000 Mg, Unk) (View Keppra Review and Keppra Label ). Patient was hospitalized.

6906252-8 | Abnormal Behaviour, Frontal Lobe Epilepsy, Product Substitution Issue
on Aug 03, 2010 Male patient from UNITED STATES , child 4 years of age, weighting 37.00 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: abnormal behaviour, frontal lobe epilepsy, product substitution issue. Oxcarbazepine dosage: 3 Ml In A.m. 4 Ml In P.m. 1x Am And 1 X Pm Po April To May. During the same period patient was treated with NASONEX (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

6880018-X | Agitation, Dysarthria, Somnolence
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, dysarthria, somnolence on Jul 23, 2010 from GERMANY Additional patient health information: Male patient , 13 years of age, weighting 103.6 lb, was diagnosed with epilepsy (What is epilepsy?) and. Oxcarbazepine dosage: 900 Mg/day. During the same period patient was treated with VALPROATE SODIUM (2000 Mg/ Day) (View Valproate Sodium Review and Valproate Sodium Label ), KEPPRA (2000 Mg/day) (View Keppra Review and Keppra Label ). Patient was hospitalized.

6867794-7 | Malaise
Adverse event was reported on Jul 21, 2010 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 2 Tabs 1x Per Day) was diagnosed with osteoarthritis (What is osteoarthritis?) and. Location: UNITED STATES , 49 years of age, weighting 156.0 lb, Patient had the following side effects: malaise.

6856040-6 | Convulsion
on Jul 16, 2010 Male patient from UNITED STATES , weighting 195.3 lb, was diagnosed with convulsion and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: convulsion. Oxcarbazepine dosage: 7.5ml Bid Oral.

6855959-X | Anxiety, Hyponatraemia, Schizophrenia, Schizophrenia, Paranoid Type
on Jul 15, 2010 Male patient from , 40 years of age, was diagnosed with mood swings, restlessness, schizophrenia, paranoid type and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), hyponatraemia, schizophrenia, schizophrenia, paranoid type. Oxcarbazepine dosage: 300 Mg. During the same period patient was treated with QUETIAPINE (600 Mg) (View Quetiapine Review and Quetiapine Label ), GABAPENTIN (900 Mg) (View Gabapentin Review and Gabapentin Label ).

6827214-5 | Abdominal Discomfort, Blood Corticotrophin Increased, Blood Cortisol Abnormal, Convulsion, Fatigue, Glucocorticoids Decreased, Nausea, Skin Hyperpigmentation
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: abdominal discomfort, blood corticotrophin increased, blood cortisol abnormal, convulsion, fatigue, glucocorticoids decreased, nausea (What is nausea?), skin hyperpigmentation on Jul 02, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 14 years of age, was diagnosed with temporal lobe epilepsy, glucocorticoids decreased and. Oxcarbazepine dosage: . During the same period patient was treated with PRASTERONE (View Prasterone Review and Prasterone Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6814038-8 | Blood Creatine Phosphokinase Increased, Confusional State, Dysphagia, Hyperthermia, Hypertonia, Leukocytosis, Neuroleptic Malignant Syndrome
Adverse event was reported on Jun 22, 2010 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: 1200 Mg Per Day) was diagnosed with epilepsy (What is epilepsy?) and. Location: GREECE , 31 years of age, After Oxcarbazepine was administered, patient had the following side effects: blood creatine phosphokinase increased, confusional state, dysphagia, hyperthermia, hypertonia, leukocytosis, neuroleptic malignant syndrome. During the same period patient was treated with OLANZAPINE (15 Mg Per Day) (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

6807107-X | Dizziness, Fatigue, Headache, Product Substitution Issue
on Jun 28, 2010 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with affective disorder and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), fatigue, headache (What is headache?), product substitution issue. Oxcarbazepine dosage: 300 Mg Twice Daily Oral O47.

6785186-6 | Anxiety, Blister, Oedema Peripheral, Pain, Rash
on Jun 21, 2010 Female patient from UNITED STATES , weighting 176.4 lb, was diagnosed with affective disorder and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), blister, oedema peripheral, pain (What is pain?), rash (What is rash?). Oxcarbazepine dosage: 150mg Bid Po. Patient was hospitalized.

6782157-0 | Abdominal Discomfort, Blood Corticotrophin Increased, Blood Cortisol Abnormal, Convulsion, Fatigue, Glucocorticoids Decreased, Nausea, Skin Hyperpigmentation
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: abdominal discomfort, blood corticotrophin increased, blood cortisol abnormal, convulsion, fatigue, glucocorticoids decreased, nausea (What is nausea?), skin hyperpigmentation on Jun 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 14 years of age, was diagnosed with temporal lobe epilepsy, glucocorticoids decreased and. Oxcarbazepine dosage: 600 Mg/day. During the same period patient was treated with DEHYDROEPIANDROSTERONE (Unk,unk) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ), HYDROCORTISONE (}22 Mg/m2/day) (View Hydrocortisone Review and Hydrocortisone Label ).

6774009-7 | Hyponatraemia
Adverse event was reported on Jun 15, 2010 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: ) . Location: UNITED STATES , 64 years of age, weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: hyponatraemia. Patient was hospitalized.

6756976-0 | Asthenia, Dehydration, Fluid Intake Reduced, Hypotension, Hypothermia, Pancytopenia, Urinary Retention
on Jun 03, 2010 Female patient from UNITED STATES , 49 years of age, weighting 237.0 lb, was diagnosed with affective disorder, psychotic disorder (What is psychotic disorder?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: asthenia, dehydration, fluid intake reduced, hypotension, hypothermia (What is hypothermia?), pancytopenia, urinary retention. Oxcarbazepine dosage: 900 Mg Bid Po. During the same period patient was treated with PERPHENAZINE (4 Mg Bid Po) (View Perphenazine Review and Perphenazine Label ). Patient was hospitalized.

6752694-3 | Anaphylactic Reaction, Angioedema
on Jun 01, 2010 Female patient from UNITED STATES , 31 years of age, weighting 125.0 lb, was diagnosed with simple partial seizures and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: anaphylactic reaction, angioedema. Oxcarbazepine dosage: 300 Mg 3x Day Po. Patient was hospitalized.

6736314-X | Grand Mal Convulsion, Product Substitution Issue
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion, product substitution issue on May 20, 2010 from UNITED STATES Additional patient health information: Male patient , 27 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Oxcarbazepine dosage: Orally Bid.

6735115-6 | Convulsion, Insomnia, Product Substitution Issue
Adverse event was reported on May 18, 2010 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: 8ml Bid Po) was diagnosed with complex partial seizures and. Location: UNITED STATES , weighting 60.41 lb, Patient had the following side effects: convulsion, insomnia, product substitution issue.

6721773-9 | Anorgasmia
on May 10, 2010 Male patient from , 41 years of age, was diagnosed with post-traumatic epilepsy and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: anorgasmia. Oxcarbazepine dosage: 900 Mg. During the same period patient was treated with PHENOBARBITAL (100 Mg) (View Phenobarbital Review and Phenobarbital Label ), LEVETIRACETAM (1500 Mg) (View Levetiracetam Review and Levetiracetam Label ).

6712646-6 | Aggression, Educational Problem, Impulse-control Disorder, Product Substitution Issue
on May 05, 2010 Male patient from UNITED STATES , child 9. years of age, was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, educational problem, impulse-control disorder, product substitution issue. Oxcarbazepine dosage: 150 Mg P.o..

6710084-3 | Bradykinesia, Cogwheel Rigidity, Gait Disturbance, Masked Facies, Posture Abnormal, Speech Disorder, Tremor
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: bradykinesia, cogwheel rigidity, gait disturbance, masked facies, posture abnormal, speech disorder, tremor on Apr 15, 2010 from TURKEY Additional patient health information: Female patient , 38 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and. Oxcarbazepine dosage: 900 Mg Per Day, Oral.

6708730-3 | Ataxia, Dizziness, Hyperkinesia, Nausea, Nystagmus, Somnolence
Adverse event was reported on Apr 20, 2010 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: 540 Mg, Unk) . Location: FRANCE , child 10 years of age, After Oxcarbazepine was administered, patient had the following side effects: ataxia (What is ataxia?), dizziness (What is dizziness?), hyperkinesia, nausea (What is nausea?), nystagmus, somnolence. During the same period patient was treated with CLARITHROMYCIN (250 Mg, Bid) (View Clarithromycin Review and Clarithromycin Label ), LAMOTRIGINE (100 Mg, Bid) (View Lamotrigine Review and Lamotrigine Label ), VALPROIC ACID (100 Mg, Unk) (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6698300-8 | Convulsion, Product Substitution Issue
on Apr 26, 2010 Male patient from UNITED STATES , weighting 238.1 lb, was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, product substitution issue. Oxcarbazepine dosage: .

6695352-6 | Convulsion, Product Substitution Issue
on Apr 23, 2010 Female patient from UNITED STATES , 17 years of age, weighting 136.7 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: convulsion, product substitution issue. Oxcarbazepine dosage: 10mg Bid Po.

6693998-2 | Epilepsy, Hypocalcaemia, Respiratory Tract Infection, Unresponsive To Stimuli
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: epilepsy (What is epilepsy?), hypocalcaemia, respiratory tract infection, unresponsive to stimuli on Apr 21, 2010 from Additional patient health information: Male patient , child 10 years of age, was diagnosed with epilepsy (What is epilepsy?), respiratory tract infection and. Oxcarbazepine dosage: 1050 Mg. During the same period patient was treated with CLARITHROMYCIN (500 Mg) (View Clarithromycin Review and Clarithromycin Label ), LAMOTRIGINE (100 Mg) (View Lamotrigine Review and Lamotrigine Label ), TOPIRAMATE (200 Mg) (View Topiramate Review and Topiramate Label ), SODIUM VALPROATE (400 Mg) (View Sodium Valproate Review and Sodium Valproate Label ). Patient was hospitalized.

6691553-1 | Ataxia, Dizziness, Hyperkinesia, Nystagmus, Somnolence, Therapeutic Agent Toxicity, Vomiting
Adverse event was reported on Apr 12, 2010 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: ) was diagnosed with respiratory tract infection and. Location: FRANCE , child 10 years of age, Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), dizziness (What is dizziness?), hyperkinesia, nystagmus, somnolence, therapeutic agent toxicity, vomiting. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6687800-2 | Ataxia, Dizziness, Hyperkinesia, Nystagmus, Somnolence, Vomiting
on Apr 06, 2010 Male patient from FRANCE , child 10 years of age, was diagnosed with respiratory tract infection and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: ataxia (What is ataxia?), dizziness (What is dizziness?), hyperkinesia, nystagmus, somnolence, vomiting. Oxcarbazepine dosage: 540 Mg, Unk. During the same period patient was treated with CLARITHROMYCIN (250 Mg, Bid) (View Clarithromycin Review and Clarithromycin Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6676730-8 | Condition Aggravated, Convulsion, Product Substitution Issue
on Apr 09, 2010 Female patient from UNITED STATES , weighting 55.12 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: condition aggravated, convulsion, product substitution issue. Oxcarbazepine dosage: 300mg Bid By Mouth.

6655889-2 | Body Mass Index Increased, Bone Disorder, Epilepsy, Grand Mal Convulsion, Hyperglycaemia, Hypoglycaemia, Hyponatraemia, Insulinoma, Surgery
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: body mass index increased, bone disorder, epilepsy (What is epilepsy?), grand mal convulsion, hyperglycaemia, hypoglycaemia, hyponatraemia, insulinoma, surgery (What is surgery?) on Mar 15, 2010 from TURKEY Additional patient health information: Female patient , 35 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Oxcarbazepine dosage: 300 Mg, Daily.

6655330-X | Influenza Like Illness, Lymphadenopathy, Lymphocyte Count Decreased, Oropharyngeal Pain, Petechiae, Pyrexia
Adverse event was reported on Mar 17, 2010 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 300 Mg, Bid) was diagnosed with affective disorder, dyspepsia, agitation, constipation (What is constipation?) and. Location: UNITED KINGDOM , 47 years of age, Patient had the following side effects: influenza like illness, lymphadenopathy, lymphocyte count decreased, oropharyngeal pain, petechiae, pyrexia. During the same period patient was treated with LAMOTRIGINE (150 Mg, Bid) (View Lamotrigine Review and Lamotrigine Label ), LANSOPRAZOLE (15 Mg, Unk) (View Lansoprazole Review and Lansoprazole Label ), LITHIUM (1000 Mg, Unk) (View Lithium Review and Lithium Label ), OLANZAPINE (20 Mg, Unk) (View Olanzapine Review and Olanzapine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SENNA (Unk) (View Senna Review and Senna Label ).

6651165-2 | Anxiety, Dyspnoea, Mood Altered, Panic Reaction, Vertigo
on Mar 11, 2010 Male patient from , weighting 174.2 lb, was diagnosed with affective disorder, hypertension, bipolar ii disorder, gastrooesophageal reflux disease and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: anxiety (What is anxiety?), dyspnoea, mood altered, panic reaction, vertigo. Oxcarbazepine dosage: 1800 Mg. During the same period patient was treated with AMLODIPINE (10 Mg) (View Amlodipine Review and Amlodipine Label ), LAMICTAL CD (250 Mg) (View Lamictal Cd Review and Lamictal Cd Label ), FLOMAX (View Flomax Review and Flomax Label ), OMEPRAZOLE (80 Mg) (View Omeprazole Review and Omeprazole Label ), LISINOPRIL (10 Mg) (View Lisinopril Review and Lisinopril Label ).

6647662-6 | Blood Sodium Decreased, Mental Status Changes, Vomiting
on Mar 23, 2010 Female patient from UNITED STATES , weighting 95.24 lb, was diagnosed with convulsion and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, mental status changes, vomiting. Oxcarbazepine dosage: 600mg Tid Po. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), DIASTAT (View Diastat Review and Diastat Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM W VIT D 2 (View Calcium W Vit D-2 Review and Calcium W Vit D-2 Label ), CHROMIUM PICOLINATE (View Chromium Picolinate Review and Chromium Picolinate Label ), DOCUSATE (View Docusate Review and Docusate Label ), FORTICAL (View Fortical Review and Fortical Label ). Patient was hospitalized.

6647073-3 | Neutropenia
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: neutropenia on Mar 22, 2010 from Additional patient health information: Female patient , 33 years of age, was diagnosed with mania, bipolar i disorder and. Oxcarbazepine dosage: 600 Mg. During the same period patient was treated with CLONAZEPAM (0.5 Mg) (View Clonazepam Review and Clonazepam Label ), LITHIUM (600 Mg) (View Lithium Review and Lithium Label ).

6641622-7 | Condition Aggravated, Convulsion
Adverse event was reported on Mar 17, 2010 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 1 Tab Am, 1/2 Tab Hs Twice Daily Po) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , child 11 years of age, weighting 94.80 lb, After Oxcarbazepine was administered, patient had the following side effects: condition aggravated, convulsion.

6637811-8 | Acne, Affect Lability, Bipolar I Disorder, Haematotoxicity, Insomnia, Logorrhoea, Mania, Neutropenia, Psychomotor Hyperactivity
on Mar 02, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 33 years of age, was diagnosed with mania and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: acne (What is acne?), affect lability, bipolar i disorder, haematotoxicity, insomnia, logorrhoea, mania, neutropenia, psychomotor hyperactivity. Oxcarbazepine dosage: Unk. During the same period patient was treated with CLONAZEPAM (0.5 Mg/day) (View Clonazepam Review and Clonazepam Label ), LITHIUM CARBONATE (Unk) (View Lithium Carbonate Review and Lithium Carbonate Label ), VALPROAT (Unk) (View Valproat Review and Valproat Label ), RISPERIDONE (Unk) (View Risperidone Review and Risperidone Label ), QUETIAPINE (Unk) (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

6635620-7 | Condition Aggravated, Convulsion, Product Substitution Issue
on Mar 12, 2010 Male patient from UNITED STATES , weighting 134.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: condition aggravated, convulsion, product substitution issue. Oxcarbazepine dosage: 300 Mg 3 1/2 Tabs Bid P.o..

6620130-3 | Convulsion, Product Substitution Issue
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: convulsion, product substitution issue on Mar 08, 2010 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Oxcarbazepine dosage: 1 1/2 Tab Bid P.o..

6618744-X | Depression
Adverse event was reported on Mar 05, 2010 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: depression (What is depression?).

6617945-4 | Ataxia, Blood Calcium Decreased, Dizziness, Electroencephalogram Abnormal, Epilepsy, Gait Disturbance, Hyperkinesia
on Feb 17, 2010 Male patient from FRANCE , child 10 years of age, was diagnosed with epilepsy (What is epilepsy?), respiratory tract infection and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: ataxia (What is ataxia?), blood calcium decreased, dizziness (What is dizziness?), electroencephalogram abnormal, epilepsy (What is epilepsy?), gait disturbance, hyperkinesia. Oxcarbazepine dosage: 540 Mg Am/510 Mg Nocte. During the same period patient was treated with CLARITHROMYCIN (250 Mg, Bid) (View Clarithromycin Review and Clarithromycin Label ), LAMOTRIGINE (100 Mg, Bid) (View Lamotrigine Review and Lamotrigine Label ), VALPROATE SODIUM (100 Mg Am/300 Mg) (View Valproate Sodium Review and Valproate Sodium Label ), TOPIRAMATE (100 Mg, Bid) (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6611811-6 | Product Substitution Issue, Tooth Discolouration
on Feb 25, 2010 Male patient from UNITED STATES , child 6 years of age, weighting 55.00 lb, was diagnosed with convulsion and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: product substitution issue, tooth discolouration. Oxcarbazepine dosage: 300mg/5ml 2x A Day Po.

6600680-6 | Neutropenia
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia on Feb 23, 2010 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 200.0 lb, . Oxcarbazepine dosage: 150 Mg Bid Po.

6589737-6 | Parkinsonism
Adverse event was reported on Feb 05, 2010 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 900 Mg, Unk) was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and. Location: TURKEY , 38 years of age, Patient had the following side effects: parkinsonism.

6588990-2 | Parkinsonism
on Feb 16, 2010 Female patient from , 38 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: parkinsonism. Oxcarbazepine dosage: 900 Mg.

6587528-3 | Parkinsonism
on Feb 04, 2010 Female patient from TURKEY , 38 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: parkinsonism. Oxcarbazepine dosage: 900 Mg, Unk.

6583758-5 | Diet Refusal, Headache, Irritability
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: diet refusal, headache (What is headache?), irritability on Feb 12, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 246.0 lb, . Oxcarbazepine dosage: 3ml Po Bid.